logo
Share SHARE
FONT-SIZE Plus   Neg

Tungsten Plans To Float In LSE; To Buy OB10 Limited - Quick Facts

Tungsten Corporation plc. said that it plans to seek admission to trading on the AIM market of the London Stock Exchange. Tungsten announced the conditional acquisition of OB10 Limited, a global business-to-business or "B2B" e-invoicing network, for 99 million pounds in cash and shares.

Tungsten also noted that it has signed a 5 year rolling licence agreement with @UK PLC to deploy its analytic software technology to enable TungstenAnalytics to be delivered across Tungsten's global e-invoicing network following the acquisition of OB10.

Tungsten also announced its agreement to acquire an identified duly authorised UK bank, whose assets solely comprise short term UK gilts and / or certificates of deposit to specialise in the provision of supply chain financing.

Tungsten is proposing to raise gross proceeds of up to 160 million pounds pursuant to a placing of new ordinary shares. The company said that it will use the proceeds of 73 million pounds to finance the cash element of the OB10 consideration, payable to OB10's Shareholders. The company also said it will use 50 million pounds - 58 million pounds to finance the completion of the acquisition of the Bank for 30 million pounds and provide solvency capital to Tungsten to support its invoice discounting activities.

It is expected that completion of each of the acquisition of OB10, the Placing and Admission will take place in October 2013.

Tungsten will be led by Edmund Truell as Group CEO, overseen by a highly regarded Non-Executive Board of Arnold Hoevenaars (Chairman), Peter Kiernan, Michael Spencer and Danny Truell; and supported by the executive management team of Luke McKeever, Philip Ashdown and Jeffrey Belkin.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT